Klemens Barth, MD

Commentary

Identifying the Vulnerable Plaque (IAGS Proceedings - Part I of II parts)

08/01/2008

Jim Zidar: We have chosen magnetic resonance imaging as our primary imaging tool at Duke University. A new cardiac magnetic resonance imaging research laboratory is being installed at Duke, with an adjacent clinical laboratory. In our view,...

Jim Zidar: We have chosen...

08/01/2008

Journal of Invasive Cardiology

Commentary

Identifying the Vulnerable Plaque (IAGS Proceedings - Part II of II)

08/01/2008

Klemens Barth , MD;

Mike Cowley , MD;

James P. Zidar , MD;

(IAGS Proceedings - Part II of II) Nick Hopkins: The preliminary reports on intracranial angioplasty and stenting showed very high morbidity and mortality rates associated with the procedure — particularly in symptomatic patients. As Dr....

(IAGS Proceedings - Part II of...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

Percutaneous Abdominal Aortic Disease Management: Long-Term Results (IAGS 2004)

08/01/2008

Michael L. Marin , MD;

Eberhard Zeitler , MD;

Klemens Barth , MD;

Michael Lawrence-Brown , MD;

Ernst Schneider , MD;

Wolfgang Ritter , MD;

Andrew Cragg , MD;

Douglas M. Cavaye , MD;

Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...

Wolfgang Ritter: We know that...

08/01/2008

Journal of Invasive Cardiology